Each ml contains Loteprednol Etabonate Ophthalmic Suspension 0.2% w/v.

Lorinol Eye Drops contain Loteprednol Etabonate 0.2%, a topical ophthalmic corticosteroid formulated to provide effective relief from inflammation associated with seasonal allergic conjunctivitis. It helps reduce ocular itching, redness, swelling, and discomfort while delivering potent anti-inflammatory action for short-term management under medical supervision.

Lorinol Eye Drops are indicated for the treatment of seasonal allergic conjunctivitis.

Loteprednol Etabonate is a topical ophthalmic corticosteroid with potent anti-inflammatory properties. It suppresses the inflammatory response by inhibiting the production and release of inflammatory mediators, including prostaglandins, through multiple independent mechanisms. By reducing inflammatory cell activity and mediator release, Loteprednol effectively alleviates the signs and symptoms of seasonal allergic conjunctivitis, including ocular redness, itching, and swelling.

Instill one drop into the affected eye(s) four times daily, or as directed by the physician.

Lorinol Eye Drops are contraindicated in patients with known hypersensitivity to Loteprednol Etabonate or any component of the formulation. They are also contraindicated in viral diseases of the cornea and conjunctiva and fungal infections of the eye.